Reportable Segment Information (Tables)

12 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Information About Domestic and International Operations

Information about Ashland’s domestic and international operations follows. Ashland has no operations in any individual international country or single customer that represented more than 10% of sales in 2020, 2019 or 2018.

	Sales to external customers						Net assets (liabilities)				Property, plant and equipment - net
(In millions)	2020		2019		2018		2020		2019		2020		2019
United States	$	878	$	959	$	997	$	1,786	$	1,789	$	1,211	$	1,231
International		1,448		1,534		1,592		1,250		1,782		354		346
	$	2,326	$	2,493	$	2,589	$	3,036	$	3,571	$	1,565	$	1,577

Summary of Financial Information for Each Reportable Segment

The following table presents various financial information for each reportable segment for the years ended September 30, 2020, 2019 and 2018.

Ashland Global Holdings Inc. and Consolidated Subsidiaries
Reportable Segment Information
Years Ended September 30
(In millions)	2020			2019			2018
Sales
Life Sciences	$	708		$	732		$	731
Personal Care & Household		615			651			702
Consumer Specialties		1,323			1,383			1,433
Specialty Additives		589			654			686
Performance Adhesives		310			345			351
Industrial Specialties		899			999			1,037
Intermediates and Solvents		129			160			155
Intersegment sales (a)		(25	)		(49	)		(36	)
	$	2,326		$	2,493		$	2,589
Equity income
Life Sciences	$	—		$	—		$	—
Personal Care & Household		—			—			1
Consumer Specialties		—			—			1
Specialty Additives		—			—			—
Performance Adhesives		—			—			—
Industrial Specialties		—			—			—
Intermediates and Solvents		—			—			—
	$	—		$	—		$	1
Other income (expense)
Life Sciences	$	1		$	—		$	1
Personal Care & Household		—			(1	)		—
Consumer Specialties		1			(1	)		1
Specialty Additives		1			—			(6	)
Performance Adhesives		—			—			—
Industrial Specialties		1			—			(6	)
Intermediates and Solvents		—			—			—
Unallocated and other		6			5			8
	$	8		$	4		$	3
Equity and other income	$	8		$	4		$	4
Operating income (loss)
Life Sciences	$	123		$	114		$	117
Personal Care & Household		(296	)		85			105
Consumer Specialties		(173	)		199			222
Specialty Additives		(132	)		18			64
Performance Adhesives		56			58			52
Industrial Specialties		(76	)		76			116
Intermediates and Solvents		(10	)		28			25
Unallocated and other		(129	)		(137	)		(261	)
	$	(388	)	$	166		$	102

(In millions)	2020			2019			2018
Depreciation expense
Life Sciences	$	33		$	33		$	30
Personal Care & Household		41			42			45
Consumer Specialties		74			75			75
Specialty Additives		62			98			73
Performance Adhesives		13			13			13
Industrial Specialties		75			111			86
Intermediates and Solvents		13			10			11
Unallocated and other		—			3			11
	$	162		$	199		$	183
Amortization expense (b)
Life Sciences	$	27		$	28		$	30
Personal Care & Household		36			37			39
Consumer Specialties		63			65			69
Specialty Additives		19			21			21
Performance Adhesives		2			1			1
Industrial Specialties		21			22			22
Intermediates and Solvents		1			3			3
Unallocated and other		—			—			—
	$	85		$	90		$	94
EBITDA (c) (d)
Life Sciences	$	183		$	175		$	177
Personal Care & Household		(219	)		164			189
Consumer Specialties		(36	)		339			366
Specialty Additives		(51	)		137			158
Performance Adhesives		71			72			66
Industrial Specialties		20			209			224
Intermediates and Solvents		4			41			39
Unallocated and other		(129	)		(134	)		(250	)
	$	(141	)	$	455		$	379
Additions to property, plant and equipment
Life Sciences	$	51		$	54		$	43
Personal Care & Household		13			20			18
Consumer Specialties		64			74			61
Specialty Additives		59			57			65
Performance Adhesives		5			6			12
Industrial Specialties		64			63			77
Intermediates and Solvents		5			7			5
Unallocated and other		5			10			14
	$	138		$	154		$	157

(In millions)	2020		2019
Assets
Life Sciences	$	1,974	$	1,946
Personal Care & Household		939		1,366
Consumer Specialties		2,913		3,312
Specialty Additives		1,666		1,775
Performance Adhesives		591		618
Industrial Specialties		2,257		2,393
Intermediates and Solvents		161		185
Unallocated and other		1,546		1,361
	$	6,877	$	7,251
Property, plant and equipment - net
Life Sciences	$	439	$	430
Personal Care & Household		205		225
Consumer Specialties		644		655
Specialty Additives		656		633
Performance Adhesives		80		89
Industrial Specialties		736		722
Intermediates and Solvents		72		78
Unallocated and other		113		122
	$	1,565	$	1,577

(a) Intersegment sales from Intermediates and Solvents are accounted for at prices that approximate fair value. All other intersegment sales are accounted for at cost.

(b) Includes amortization of zero, $4 million and $1 million related to land-use-rights associated with other non-current assets.

(c) Excludes income (loss) from discontinued operations, other net periodic benefit income (expense) and net income (loss) on divestitures. See the Statement of Consolidated Comprehensive Income (Loss) for applicable amounts excluded.

(d) Includes zero, $39 million and $14 million of accelerated depreciation for the years ended September 30, 2020, 2019 and 2018, respectively.